share_log

樂普生物-B:自願性公告 MRG004A 用於治療胰腺癌獲FDA授予快速通道資格

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER

香港交易所 ·  Mar 10 20:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more